Related Experiment Videos

The reticulocytic rat: a model for analysis of methotrexate polyglutamate dynamics in situ

Insights

Methotrexate persists in rat red blood cells due to polyglutamate formation. Developing red blood cells (reticulocytes) accumulate these metabolites, lacking the enzyme to break them down, making the reticulocytic rat a model for studying this metabolism.

Area of Science:

  • Pharmacology
  • Biochemistry
  • Hematology

Background:

  • Methotrexate (MTX) is an antifolate drug with known persistence in certain tissues.
  • Understanding MTX metabolism in erythrocytes is crucial for explaining its prolonged effects.

Purpose of the Study:

  • To investigate the metabolism of methotrexate in rat erythrocytes.
  • To determine the basis for methotrexate's persistence in red blood cells.
  • To establish an in vivo model for studying polyglutamate metabolism.

Main Methods:

  • High-performance liquid chromatography (HPLC) and radioassay were used to detect MTX polyglutamates.
  • Density centrifugation through Percoll separated red blood cell populations.
  • Phenylhydrazine induced reticulocytosis in rats.

Main Results:

  • Methotrexate polyglutamates, up to heptaglutamate, were detected in rat erythrocytes.
  • Reticulocytes showed higher concentrations of MTX and its polyglutamates compared to normal erythrocytes.
  • Reticulocytes exhibited minimal gamma-glutamylcarboxypeptidase (conjugase) activity.

Conclusions:

  • Methotrexate polyglutamate formation occurs in developing erythrocytes (reticulocytes) within the bone marrow.
  • The lack of conjugase activity in reticulocytes contributes to MTX polyglutamate persistence.
  • The reticulocytic rat serves as a valid in vivo model for studying methotrexate polyglutamate metabolism.

Related Concept Videos